After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing. In an interview with Wired, R3 listed three investors: billionaire Tim Draper, the Singapore-based fund Immortal…
Entrepreneurs aren’t buying advice anymore. In 2026, outcome-based and done-for-you business models win by delivering real results. Here’s why clients now pay more for outcomes, not effort.